JP2019528255A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528255A5
JP2019528255A5 JP2019503247A JP2019503247A JP2019528255A5 JP 2019528255 A5 JP2019528255 A5 JP 2019528255A5 JP 2019503247 A JP2019503247 A JP 2019503247A JP 2019503247 A JP2019503247 A JP 2019503247A JP 2019528255 A5 JP2019528255 A5 JP 2019528255A5
Authority
JP
Japan
Prior art keywords
protein
optionally
elution buffer
temperature
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019503247A
Other languages
English (en)
Japanese (ja)
Other versions
JP7092744B2 (ja
JP2019528255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/043384 external-priority patent/WO2018018011A2/en
Publication of JP2019528255A publication Critical patent/JP2019528255A/ja
Publication of JP2019528255A5 publication Critical patent/JP2019528255A5/ja
Priority to JP2022096278A priority Critical patent/JP7411020B2/ja
Application granted granted Critical
Publication of JP7092744B2 publication Critical patent/JP7092744B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019503247A 2016-07-22 2017-07-21 Fc含有タンパク質を精製する方法 Active JP7092744B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022096278A JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662365943P 2016-07-22 2016-07-22
US62/365,943 2016-07-22
PCT/US2017/043384 WO2018018011A2 (en) 2016-07-22 2017-07-21 Methods of purifying fc-containing proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022096278A Division JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Publications (3)

Publication Number Publication Date
JP2019528255A JP2019528255A (ja) 2019-10-10
JP2019528255A5 true JP2019528255A5 (enExample) 2020-07-27
JP7092744B2 JP7092744B2 (ja) 2022-06-28

Family

ID=59656168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019503247A Active JP7092744B2 (ja) 2016-07-22 2017-07-21 Fc含有タンパク質を精製する方法
JP2022096278A Active JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022096278A Active JP7411020B2 (ja) 2016-07-22 2022-06-15 Fc含有タンパク質を精製する方法

Country Status (12)

Country Link
US (1) US11312745B2 (enExample)
EP (1) EP3487867B1 (enExample)
JP (2) JP7092744B2 (enExample)
KR (2) KR102435801B1 (enExample)
CN (2) CN115925780B (enExample)
AU (2) AU2017298984B2 (enExample)
CA (2) CA3031469C (enExample)
IL (2) IL285146B (enExample)
MA (1) MA45721A (enExample)
MX (2) MX2019000903A (enExample)
SG (1) SG11201900573UA (enExample)
WO (1) WO2018018011A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019343053B2 (en) * 2018-09-21 2026-04-30 Teneobio, Inc. Methods for purifying heterodimeric, multispecific antibodies
AR117650A1 (es) * 2018-10-11 2021-08-18 Amgen Inc Procesamiento posterior de constructos de anticuerpos biespecíficos
BR112021011194A2 (pt) * 2019-01-16 2021-08-31 Regeneron Pharmaceuticals, Inc. Método e sistema de identificar e quantificar a fragmentação do anticorpo
KR102286892B1 (ko) 2019-07-08 2021-08-06 삼천당제약주식회사 안과용 단백질 제제의 정제방법
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法
CN112881675A (zh) * 2019-11-29 2021-06-01 广东菲鹏生物有限公司 IgM抗体检测稀释液
CA3174665A1 (en) 2020-04-09 2021-10-14 Cytomx Therapeutics, Inc. Compositions containing activatable antibodies
CN116056775B (zh) * 2020-09-16 2025-12-02 沃特世科技公司 在尺寸排阻色谱流动相中使用低浓度氨基酸的改善尺寸排阻色谱法
WO2023068740A1 (ko) * 2021-10-19 2023-04-27 주식회사 알테오젠 Igg fc 도메인을 가지는 융합 단백질의 정제방법
CN113980092B (zh) * 2021-12-09 2024-05-14 上海药明生物技术有限公司 一种蛋白质亲和纯化方法
CN116165290B (zh) * 2021-12-17 2025-06-27 复旦大学 一种抗体药物研发流程中工程细胞株的筛选方法
CN116271982B (zh) * 2022-11-30 2024-01-09 杭州广科安德生物科技有限公司 一种血液高丰度蛋白免疫亲和柱的再生方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
WO1990005183A1 (en) 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
ES2284161T3 (es) 1990-01-12 2007-11-01 Amgen Fremont Inc. Generacion de anticuerpos xenogenicos.
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6713610B1 (en) 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US6255458B1 (en) 1990-08-29 2001-07-03 Genpharm International High affinity human antibodies and human antibodies against digoxin
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
EP0822830B1 (en) 1995-04-27 2008-04-02 Amgen Fremont Inc. Human anti-IL-8 antibodies, derived from immunized xenomice
ATE549918T1 (de) 1996-12-03 2012-04-15 Amgen Fremont Inc Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
AU763513B2 (en) * 1998-04-16 2003-07-24 Genentech Inc. Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
SG156672A1 (en) * 2004-10-22 2009-11-26 Amgen Inc Methods for refolding of recombinant antibodies
BRPI0611600B8 (pt) * 2005-06-17 2021-05-25 Wyeth Corp método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
CA2636109A1 (en) * 2006-01-06 2007-07-19 Amgen Inc. Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents
CN105837690A (zh) 2006-06-12 2016-08-10 新兴产品开发西雅图有限公司 具有效应功能的单链多价结合蛋白
WO2008036600A2 (en) * 2006-09-18 2008-03-27 Genentech, Inc. Methods of protein production
JP5522723B2 (ja) * 2007-05-21 2014-06-18 ノマディックバイオサイエンス株式会社 新規ポリペプチド,アフィニティークロマトグラフィー用材,及びイムノグロブリンの分離及び/又は精製方法
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
WO2010019493A1 (en) * 2008-08-14 2010-02-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
KR101741859B1 (ko) * 2009-06-22 2017-06-15 암젠 인크 화학적으로 조절된 산화환원 상태를 사용한 단백질의 재폴딩
SI3660032T1 (sl) * 2009-06-25 2026-02-27 Amgen Inc. Postopki zajemanja in čiščenja beljakovin, izraženih v nesesalskem sistemu
MX2012003396A (es) 2009-09-16 2012-04-10 Genentech Inc Complejos de proteina conteniendo helice super-enrollada y/o enlazador tether y usos de los mismos.
CN102382190B (zh) * 2010-09-01 2014-04-09 山东新时代药业有限公司 分离和去除TNFR-Fc融合蛋白中寡聚体的方法
WO2012086837A1 (ja) 2010-12-24 2012-06-28 旭化成メディカル株式会社 温度応答性プロテインaの固定化方法
JP6280499B2 (ja) * 2011-07-08 2018-02-14 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Fc融合タンパク質の精製方法
US10189891B2 (en) 2012-03-28 2019-01-29 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
EP2889617B1 (en) 2012-08-27 2017-10-11 Asahi Kasei Medical Co., Ltd. Antibody purification method by means of temperature-responsive chromatography
UY35148A (es) * 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US20140302037A1 (en) 2013-03-15 2014-10-09 Amgen Inc. BISPECIFIC-Fc MOLECULES
WO2015063339A1 (en) * 2013-11-04 2015-05-07 Glenmark Pharmaceuticals S.A. Production of t cell retargeting hetero-dimeric immunoglobulins

Similar Documents

Publication Publication Date Title
Cheung et al. Immobilized metal ion affinity chromatography: a review on its applications
JP5873016B2 (ja) アミノ酸を利用したタンパク質の精製方法
CN103270044B (zh) 亲和色谱用载体和分离免疫球蛋白的方法
Valliere-Douglass et al. Separation of populations of antibody variants by fine tuning of hydrophobic-interaction chromatography operating conditions
JP5944101B2 (ja) 非グリコシル化タンパク質の精製
RU2019109975A (ru) Способы очистки антител
KR101908074B1 (ko) 개선된 FVIII:C/FVIII:Ag의 비를 갖는 인자 VIII의 제조방법
RU2012130151A (ru) Промывочный раствор и способ промывки для аффинной хроматографии
US20200361986A1 (en) Capture Purification Processes for Proteins Expressed in a Non-Mammalian System
Walker et al. Techniques in Molecular Biology: Volume 2
JP6335785B2 (ja) ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子
Nascimento et al. Studies on the purification of antibody fragments
CA2467048C (en) Method of protein purification
AU2020368409A1 (en) Methods for characterizing host-cell proteins
Westra et al. Immobilised metal-ion affinity chromatography purification of histidine-tagged recombinant proteins: a wash step with a low concentration of EDTA
Arakawa et al. Solvent modulation of column chromatography
CN103703015A (zh) 阳离子和阴离子交换层析法
JP5635682B2 (ja) 疎水性相互作用クロマトグラフィー法
JP6303379B2 (ja) 抗体の精製方法
EP4483188A1 (en) Size exclusion chromatography for characterizing host cell proteins
KR20240135666A (ko) 단백질 a의 b 도메인과 z 도메인 돌연변이체, 및 이의 응용
JP2015003872A (ja) マウスIgGの精製方法
Arakawa et al. Stress-free chromatography: affinity chromatography
CN118922720A (zh) 用于表征宿主细胞蛋白的尺寸排阻色谱法
TR2022013896A2 (tr) Proteaza Dirençli Küçük Peptitler ile Antikor Saflaştıran Reçine ve Kromatografi Kolonu